EGFR and head and neck squamous cell carcinoma: The goal of this study was to investigate the therapeutic outcome of integrating a novel targeting photosensitizer, Pyro PA (LCP Pyro PA NPs mediated PDT), with LCP NPs with EGFR siRNA gene therapy and targeting AEAA ligands loaded to treat HNSCC in xenograft animal models (Scheme 1).